Global Chronic Fatigue Syndrome Therapeutics Market 2019-2023 | Increasing Risk Factors of CFS to Boost Demand | Technavio

Technavio has announced its latest market research report titled global chronic fatigue syndrome therapeutics market 2019-2023. (Graphic: Business Wire)

LONDON--()--The global chronic fatigue syndrome therapeutics market size is poised to grow by USD 44.31 million during 2019-2023, according to a new report by Technavio, progressing at a CAGR of more than 4% during the forecast period.

Read the 127-page research report with TOC on "Chronic Fatigue Syndrome Therapeutics Market Analysis Report by product (pain relievers and NSAIDs; antidepressant and antipsychotic drugs; and antimicrobial and immunomodulatory drugs), and geography (North America, Europe, Asia, and ROW) 2019 - 2023". Request a Free Sample Report

The market is driven by the increasing risk factors of CFS. In addition, the initiatives to increase awareness about CFS are expected to further boost the growth of the chronic fatigue syndrome therapeutics market.

Although the definitive cause of CFS is unidentified till date, some theories indicate that viral infection, psychological stress, genetic factors, and or a combination of these factors increase the risk of CFS. The prevalence of CFS is four times more in women than in men. Hence, the increase in the number of middle-aged women is expected to increase the risk of CFS. Therefore, the increasing risk factors of CFS will fuel the growth of the CFS therapeutics market during the forecast period.

Several public and private organizations are increasingly undertaking initiatives to increase awareness about CFS. For instance, the Solve ME/CFS Initiative, an American not-for-profit association dedicated to ending ME/CFS, celebrates May 12 as international awareness day for ME/CFS. Such initiatives to raise awareness and to help people understand the seriousness of ME/CFS are expected to drive the growth of the CFS therapeutics market.

For More Information: Request Free Sample Pages

The report includes detailed profiles of the leading companies & prominent vendors of the market:

  • Hemispherx Biopharma Inc.
  • Lupin Ltd.
  • Mylan NV
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.

Market Segmentation by Product:

The chronic fatigue syndrome therapeutics market can be broadly categorized into the following segments:

  • Pain relievers and NSAIDs
  • Antidepressant and antipsychotic drugs
  • Antimicrobial and immunomodulatory drugs

Key Regions for the Chronic Fatigue Syndrome Therapeutics Market:

Featuring a breakdown of region-wise market shares until 2019.

  • North America
  • Europe
  • Asia
  • ROW

Some of the key topics covered in the report include:

Market Landscape

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis 

Market Sizing

  • Market definition
  • Market size and forecast 

Vendor Landscape

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Competitive scenario

Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request a free sample report

Related Reports on Healthcare are:

Kidney Stones Management Devices Market – Global Kidney Stones Management Devices Market by procedure (URS, ESWL, and PCNL) and geography (Asia, Europe, North America, and ROW).

Polycystic Kidney Disease Drugs Market – Global Polycystic Kidney Disease Drugs Market by type (ADPKD and ARPKD) and geography (Asia, Europe, North America, and ROW).

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at media@technavio.com.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
www.technavio.com

Release Summary

The global chronic fatigue syndrome therapeutics market size is poised to grow by USD 44.31 million during 2019-2023, according to Technavio.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
www.technavio.com